The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Market Overview and Growth Trajectory

• The HTS market has experienced rapid growth, expanding from $20.66 billion in 2023 to $22.98 billion in 2024, with a CAGR of 11.2%.
• Forecasted to reach $33.1 billion by 2028, growing at a CAGR of 9.5%.
• Drivers include increased R&D spending, rising healthcare investments, and a competitive market environment.

Impact of Chronic Disease Prevalence on HTS Market Growth

• Chronic diseases drive demand for HTS by necessitating effective drug discovery and disease management solutions.
• The prevalence of chronic diseases is projected to significantly increase, amplifying market growth.

View More On The High Throughput Screening (HTS) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

Key Players Driving Innovation

• Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, among others, are pivotal in market expansion.
• Continuous innovation in multimode plate readers enhances screening efficiency and accuracy.

Innovative Multimode Plate Reader Revolutionizes HTS Market

• PerkinElmer Inc.’s EnVision Nexus system sets new benchmarks in HTS capabilities.
• Features dual detectors, optimized reagents, and automation for unparalleled efficiency.

PerkinElmer Inc.’s Strategic Expansion

• Acquisition of Covaris Inc. enhances PerkinElmer’s diagnostic capabilities and market footprint.

Market Segmentation

1. Products and Services
   • Consumables and Reagents
   • Instruments
   • Software and Services
2. Technology
   • Ultra-High-Throughput Screening
   • Cell-Based Assays
   • Lab-on-a-chip
   • Label-Free Technology
3. Application
   • Target Identification and Validation
   • Primary and Secondary Screening
   • Toxicology Assessment
   • Other Applications
4. End User
   • Pharmaceuticals and Biotechnology Industry
   • Academics and Research Institutes
   • Contract Research Organizations
   • Other End Users

Regional Insights

• North America led the HTS market in 2023, while Asia-Pacific shows the fastest growth potential.

Conclusion
The HTS market is poised for substantial growth driven by technological advancements, rising chronic disease prevalence, and strategic expansions by key players. As innovation continues to thrive, the sector’s ability to expedite drug discovery and disease management will solidify its pivotal role in global healthcare.

Request A Sample Of The Global High Throughput Screening (HTS) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=14116&type=smp